Ignite Creation Date:
2024-05-06 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 12:44 PM
Study NCT ID:
NCT03504852
Status:
COMPLETED
Last Update Posted:
2021-10-11
First Post:
2018-03-29
Brief Title:
Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With ModerateSevere Chronic Plaque Psoriasis
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis